Standard
Antithrombin III in critically ill patients: systematic review with meta-analysis and trial sequential analysis. / Afshari, Arash; Wetterslev, Jørn; Brok, Jesper Sune; Møller, Ann.
In:
B M J, Vol. 335, No. 7632, 15.12.2007, p. 1248-51.
Research output: Contribution to journal › Journal article › Research › peer-review
Harvard
Afshari, A, Wetterslev, J, Brok, JS
& Møller, A 2007, '
Antithrombin III in critically ill patients: systematic review with meta-analysis and trial sequential analysis',
B M J, vol. 335, no. 7632, pp. 1248-51.
https://doi.org/10.1136/bmj.39398.682500.25
APA
Afshari, A., Wetterslev, J., Brok, J. S.
, & Møller, A. (2007).
Antithrombin III in critically ill patients: systematic review with meta-analysis and trial sequential analysis.
B M J,
335(7632), 1248-51.
https://doi.org/10.1136/bmj.39398.682500.25
Vancouver
Afshari A, Wetterslev J, Brok JS
, Møller A.
Antithrombin III in critically ill patients: systematic review with meta-analysis and trial sequential analysis.
B M J. 2007 Dec 15;335(7632):1248-51.
https://doi.org/10.1136/bmj.39398.682500.25
Author
Afshari, Arash ; Wetterslev, Jørn ; Brok, Jesper Sune ; Møller, Ann. / Antithrombin III in critically ill patients: systematic review with meta-analysis and trial sequential analysis. In: B M J. 2007 ; Vol. 335, No. 7632. pp. 1248-51.
Bibtex
@article{27a266c469d843d0b6c1567e4bc8b5ea,
title = "Antithrombin III in critically ill patients: systematic review with meta-analysis and trial sequential analysis",
abstract = "To evaluate the benefits and harms of antithrombin III in critically ill patients.",
author = "Arash Afshari and J{\o}rn Wetterslev and Brok, {Jesper Sune} and Ann M{\o}ller",
year = "2007",
month = dec,
day = "15",
doi = "http://dx.doi.org/10.1136/bmj.39398.682500.25",
language = "English",
volume = "335",
pages = "1248--51",
journal = "The BMJ",
issn = "0959-8146",
publisher = "BMJ Publishing Group",
number = "7632",
}
RIS
TY - JOUR
T1 - Antithrombin III in critically ill patients: systematic review with meta-analysis and trial sequential analysis
AU - Afshari, Arash
AU - Wetterslev, Jørn
AU - Brok, Jesper Sune
AU - Møller, Ann
PY - 2007/12/15
Y1 - 2007/12/15
N2 - To evaluate the benefits and harms of antithrombin III in critically ill patients.
AB - To evaluate the benefits and harms of antithrombin III in critically ill patients.
U2 - http://dx.doi.org/10.1136/bmj.39398.682500.25
DO - http://dx.doi.org/10.1136/bmj.39398.682500.25
M3 - Journal article
VL - 335
SP - 1248
EP - 1251
JO - The BMJ
JF - The BMJ
SN - 0959-8146
IS - 7632
ER -